To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.

Also called NCT03089450

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 112 participants (planned count) (from the registry)
Sponsor
CGBio Inc. (from the registry)
Registry
  • NCT NCT03089450
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03089450. Randomized; single masking; primary purpose treatment. Start 2017-03-22 (actual); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
Condition
Ischemic Heart Disease
Condition
Stable Coronary Artery Disease
Condition
Stable Angina
Condition
Unstable Angina
Condition
NSTEMI - Non-ST Segment Elevation MI
Intervention (Device)
CGBio stent
Intervention (Device)
Biomatrix flex
Lead sponsor
CGBio Inc. (class: industry)

Record details

Record id
cardio:ct-nct03089450
Content hash
5085b5bc6704df8643740ed7173b3f68cc00a1776d6078fd31b778448d3acea7